Ons laatste Nieuws
Bekijk alle nieuwsberichten op farmaactueel.nl
20 mei
Alliance Boots Preliminary results announcement for the year ended 31 March 2012
“International expansion drives growth”
Highlights:
Group
• Revenue up 18.4% to £23.0 billion – £25.4 billion including share of associates and joint ventures
• EBITDA up 10.2% to £1,443 million – £1,568 million including share of associates and joint ventures
• Trading profit up 12.4% to £1,195 million – £1,300 million including share of associates and joint ventures
• Underlying profit (after tax) up 10.2% to £693 million
• Cash generated from operations up 22.3% to £1,601 million
• Year end net borrowings reduced by £826 million
Health & Beauty Division
• Revenue up 0.6%
• Trading profit up 6.0%
• Boots UK
– Like for like dispensing volume up 1.9%
– Like for like retail revenue up 0.8% (incl. VAT)
Pharmaceutical Wholesale Division
• Revenue up 27.9%
– Like for like revenue up 2.4%
• Trading profit up 24.7%
– Like for like trading profit up 8.2%
Stefano Pessina, Executive Chairman, commented:
“Alliance Boots has again delivered double digit growth in trading profit while at the same time generating a
strong operating cash flow to fund investment in growth and substantially reduce net borrowings. This
performance, which reflects the excellent work of our teams, has been achieved through a combination of organic growth and benefits from the previous year’s acquisitions, is particularly encouraging given the challenging economic environment."
“In the coming year, we expect the economic environment to remain difficult with continuing pressure on both
consumer and governmental expenditure. This will generate both challenges and new opportunities for us."
“We are confident about our future prospects and ability to pursue profitable growth, both organically and through further international expansion. This will be supported by our strong operating cash flow and secure funding arrangements, which will enable us to continue to invest while at the same time reducing net borrowings. The development of new and existing partnerships will be a key component of our future growth.”
Reconciliations of trading profit to profit from operations before associates and joint ventures, and underlying
profit to profit for the year, are set out in the financial review section of this announcement.
Blijf op de hoogte
Wilt u altijd op de hoogte blijven van de laatste veranderingen en nieuws over Farma-actueel? Vraag de nieuwsbrief aan door uw e-mailadres hieronder in te vullen.